GO
Loading...

U.S. Video

Ebola patient in Dallas hospital     Wed, 1 Oct '14 | 7:03 AM ET

The traveler from Liberia is the first Ebola patient diagnosed in the U.S., reports CNBC's Meg Tirrell.

Robert Reffkin, Urban Compass founder & CEO, talks about building his business in New York and the company's plans to expand into other locations.

David Strauss, UBS aerospace & defense analyst, discusses his "sell" rating and $157 price target on shares of Lockheed Martin.

Betting on Pimco's future     Wed, 1 Oct '14 | 6:35 AM ET

Greg Zuckerman, Wall Street Journal special writer, shares his thoughts on the future of Pimco now that Bill Gross has left.

Jim Russell, U.S. Bank Wealth Management, and James Liu, J.P. Morgan Funds, provide perspective on what's driving the market higher and look ahead to fourth quarter expectations.

Ebola stocks to watch     Wed, 1 Oct '14 | 6:21 AM ET

CNBC's Dominic Chu puts together a list of companies that could be impacted by the deadly Ebola virus.

Hong Kong protesters not budging     Wed, 1 Oct '14 | 6:10 AM ET

Pro-democracy protesters defied calls by Beijing to disperse, reports CNBC's Susan Li, with the latest details on the Hong Kong uprising.

Ebola diagnosed in Texas patient     Wed, 1 Oct '14 | 6:02 AM ET

CNBC's Meg Tirrell reports the latest details on the first confirmed case of the deadly virus found in the U.S. and the risk to Americans.

Shares of Canada's Tekmira Pharmaceuticals soared in premarket trading Wednesday on prospects for its Ebola treatment. So did, Massachusetts-based Sarepta Therapeutics.

Cramer: These stocks should be sold     Tue, 30 Sep '14 | 7:00 PM ET

Are they hiding in your portfolio? Mad Money host Jim Cramer says get rid of 'em.

Netflix's stock may have gotten a nice pop because of a new film announcement, but one analyst who covers the name has come out to say it's "way overvalued." With CNBC's Mandy Drury.

Ford's warning to the world     Tue, 30 Sep '14 | 5:05 PM ET

Ford shares are stalling out, and the decline could have broader implications for the stock market, according to some market watchers. With CNBC's Melissa Lee.

Some traders are wondering if the Golden Arches could be the next great activist target. With CNBC's Melissa Lee.

Cramer's cruise stock picks     Tue, 30 Sep '14 | 6:25 PM ET

Mad Money host Jim Cramer shares his top three picks in the cruise space.

Death Cross: Panic or nothing to fear?     Tue, 30 Sep '14 | 6:15 PM ET

Mad Money host Jim Cramer turns to the charts to check out whether the so-called "Death Cross" indicator may be nothing to fear.

Cramer reflects on market peaks     Tue, 30 Sep '14 | 6:00 PM ET

Mad Money host Jim Cramer reflects on this year's market trends as the third quarter ends.

Your first trade for Wednesday     Tue, 30 Sep '14 | 5:59 PM ET

The Fast Money traders share their final trades of the day and what they're looking out for on Wednesday.

Angie's List spikes after hours     Tue, 30 Sep '14 | 5:58 PM ET

Shares of Angie's List spike after hours following an FT report the company has hired bankers and may consider a sale, reports Dominic Chu.

October playbook: Google, Ryder & more     Tue, 30 Sep '14 | 5:39 PM ET

Your best plays for October, with Paul Hickey, Bespoke Investment Group.

CNBC's Meg Tirrell provides insight to comments by the CDC director about the first confirmed Ebola case in the U.S.

David L. Lakey, M.D., Commissioner of the Texas Department of State Health Services, discusses the handling of the patient with Ebola.

Awaiting CDC news conference     Tue, 30 Sep '14 | 5:37 PM ET

CNBC's Melissa Lee reports pharmaceutical companies with potential Ebola treatments are on the move after hours, as well as airline stocks.

CDC's Ebola strategy     Tue, 30 Sep '14 | 5:45 PM ET

CDC Director Dr. Tom Frieden explains the CDC's investment to ensuring the spread of Ebola is stopped.

CDC Director Dr. Tom Frieden provides insight to the spread of Ebola, and announces an individual traveling from Liberia to the United States has been diagnosed with Ebola in Texas.

Sarepta President and CEO Chris Garabedian says his company has enough clinical trial quality drug on hand to treat a couple dozen Ebola patients if requested.

Profiting from prisons     Tue, 30 Sep '14 | 5:00 PM ET

America has the highest incarceration rate in the world, and that opens up the door for companies to have a captive market -- literally. One of those companies is JPay, which provides electronic money transfers and other services to about 70 percent of state prisons. But in order to get that lucrative state prison contract, the state takes a commission as well. Critics argue all the costs are passed down to families and inmates, often burdening them financially. CNBC's Dina Gusovsky Reports.

Would you believe that an inmate at a maximum security facility -- whether he is charged with a minor drug offense or quadruple homicide is able to use a tablet computer to listen to the radio, email, get video grams and play games? We visited a maximum security facility in North Dakota to get a first-hand look at tech behind bars. CNBC's Dina Gusovsky reports.

October could bring stock market gains     Tue, 30 Sep '14 | 5:30 PM ET

Patti Domm discusses events that may lead up to market volatility in October.

CNBC's Meg Tirrell reports Texas health officials have confirmed the Ebola patient is in Texas, and had a recent history of travel to West Africa.

MGM Resorts Chairman and CEO Jim Murren discusses whether Hong Kong protests could negatively impact his business in Macau, and the future of the gaming and slot floor.

Contact U.S. Video

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    › Learn More

CNBC TV Worldwide

  • The reality series features the sharks who give budding entrepreneurs the chance to make their dreams come true.

  • “Restaurant Startup” is on a quest to discover, invest in and launch America's next generation of epicurean superstars.

  • CNBC's "American Greed" examines the dark side of the American dream. Some people will do anything for money!